Hepatitis C vaccine - GC BioPharma
Latest Information Update: 01 Apr 2022
At a glance
- Originator Green Cross
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 29 Mar 2022 GC Pharma is now called GC Biopharma
- 16 Jul 2016 No recent reports of development identified for research development in Hepatitis-C in South Korea
- 03 Aug 2005 Early research in Hepatitis C in South Korea (unspecified route)